Koumine, an alkaloid found in Gelsemium elegans, alleviates osteoarthritis in rats by increasing mitochondrial autophagy and reducing inflammation and cartilage erosion. This suggests potential for treating OA in humans.
Researchers discovered two new alkaloids, along with six known analogues, in Gelsemium elegans. These compounds showed anti-inflammatory activity and inhibited osteoclast formation, suggesting potential therapeutic applications for G. elegans.
Scientists studied the reference genes in a medicinal plant under different hormone treatments to understand gelsenicine synthesis. They found three genes that strongly correlated with gelsenicine levels. This research will help future molecular analyses of this plant.
Gelsemium elegans, a traditional medicine, contains Koumine, which can reduce inflammation by modulating macrophage activation and polarization. This research might have potential applications in treating inflammatory conditions.
Gelsemium plants are popular for their medicinal properties, treating various issues like skin problems, neuralgia, fractures, and cancer. They are also used to reduce inflammation and blood flow to spinal and cerebrospinal centers.
Gelsevirine reduces stroke damage by decreasing inflammation and apoptotic cells, improving neurobiological function, and downregulating microglia activity and JAK-STAT signal pathway.
Gelsemine, an alkaloid found in plants with therapeutic and toxic effects, may be involved in the modulation of GABA receptors (GABARs) responsible for the properties of benzodiazepines (BDZs), drugs used to treat anxiety, insomnia, and pain. Through electrophysiological recordings in HEK293 cells and cortical neurons, researchers discovered that gelsemine acts as a negative modulator of GABARs and GABAergic synaptic function, leading to toxicity. However, its presynaptic effects also provide a potential mechanism for its therapeutic effects. These findings improve understanding of gelsemine's effects in the nervous system and suggest potential new targets for therapeutic agents.